cefadroxil anhydrous has been researched along with Infections, Prosthesis-Related in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Lipson, S; Menendez, ME; Moverman, MA; Pagani, NR; Puzzitiello, RN; Smith, EL | 1 |
Ali, M; El-Sayed Ahmed, MM; Haddad, O; Pham, AN; Pham, SM; Sareyyupoglu, B; Thomas, M | 1 |
Azzam, KA; Dilley, JE; Inabathula, A; Ireland, PH; Meneghini, RM; Warth, LC; Ziemba-Davis, M | 1 |
3 other study(ies) available for cefadroxil anhydrous and Infections, Prosthesis-Related
Article | Year |
---|---|
The Cost-Effectiveness of Extended Oral Antibiotic Prophylaxis for Infection Prevention After Total Joint Arthroplasty in High-Risk Patients.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Cefadroxil; Cost-Benefit Analysis; Humans; Prosthesis-Related Infections; Retrospective Studies | 2022 |
Absorbable antibiotic beads as an adjuvant therapy in treating ventricular assist devices driveline infection: A case report.
Topics: Adult; Anti-Bacterial Agents; Calcium Sulfate; Cardiomyopathies; Cefadroxil; Cefazolin; Chemotherapy, Adjuvant; Debridement; Dosage Forms; Drug Therapy, Combination; Heart-Assist Devices; Humans; Male; Prosthesis-Related Infections; Staphylococcus aureus; Tobramycin; Treatment Outcome; Vancomycin | 2020 |
Extended Oral Antibiotic Prophylaxis in High-Risk Patients Substantially Reduces Primary Total Hip and Knee Arthroplasty 90-Day Infection Rate.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cefadroxil; Clindamycin; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Prosthesis-Related Infections; Retrospective Studies; Risk Factors; Staphylococcal Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |